rs45498491

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001114134.2(EPB42):​c.1318+4C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0184 in 1,613,806 control chromosomes in the GnomAD database, including 326 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.015 ( 29 hom., cov: 32)
Exomes 𝑓: 0.019 ( 297 hom. )

Consequence

EPB42
NM_001114134.2 splice_region, intron

Scores

2
Splicing: ADA: 0.00008317
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.938

Publications

3 publications found
Variant links:
Genes affected
EPB42 (HGNC:3381): (erythrocyte membrane protein band 4.2) Erythrocyte membrane protein band 4.2 is an ATP-binding protein which may regulate the association of protein 3 with ankyrin. It probably has a role in erythrocyte shape and mechanical property regulation. Mutations in the EPB42 gene are associated with recessive spherocytic elliptocytosis and recessively transmitted hereditary hemolytic anemia. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
EPB42 Gene-Disease associations (from GenCC):
  • hereditary spherocytosis type 5
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • hereditary spherocytosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant 15-43207195-G-A is Benign according to our data. Variant chr15-43207195-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 255149.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0148 (2254/152236) while in subpopulation NFE AF = 0.0212 (1439/68000). AF 95% confidence interval is 0.0203. There are 29 homozygotes in GnomAd4. There are 1041 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 29 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EPB42NM_001114134.2 linkc.1318+4C>T splice_region_variant, intron_variant Intron 9 of 12 ENST00000441366.7 NP_001107606.1 P16452-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EPB42ENST00000441366.7 linkc.1318+4C>T splice_region_variant, intron_variant Intron 9 of 12 1 NM_001114134.2 ENSP00000396616.2 P16452-1

Frequencies

GnomAD3 genomes
AF:
0.0148
AC:
2255
AN:
152118
Hom.:
29
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00328
Gnomad AMI
AF:
0.0318
Gnomad AMR
AF:
0.0168
Gnomad ASJ
AF:
0.0441
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00186
Gnomad FIN
AF:
0.0153
Gnomad MID
AF:
0.0605
Gnomad NFE
AF:
0.0212
Gnomad OTH
AF:
0.0239
GnomAD2 exomes
AF:
0.0169
AC:
4222
AN:
250552
AF XY:
0.0165
show subpopulations
Gnomad AFR exome
AF:
0.00271
Gnomad AMR exome
AF:
0.0139
Gnomad ASJ exome
AF:
0.0474
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0161
Gnomad NFE exome
AF:
0.0235
Gnomad OTH exome
AF:
0.0209
GnomAD4 exome
AF:
0.0188
AC:
27453
AN:
1461570
Hom.:
297
Cov.:
32
AF XY:
0.0184
AC XY:
13373
AN XY:
727102
show subpopulations
African (AFR)
AF:
0.00358
AC:
120
AN:
33476
American (AMR)
AF:
0.0144
AC:
645
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0468
AC:
1224
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.00330
AC:
285
AN:
86244
European-Finnish (FIN)
AF:
0.0166
AC:
884
AN:
53364
Middle Eastern (MID)
AF:
0.0488
AC:
280
AN:
5740
European-Non Finnish (NFE)
AF:
0.0207
AC:
22963
AN:
1111802
Other (OTH)
AF:
0.0174
AC:
1052
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1623
3245
4868
6490
8113
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
830
1660
2490
3320
4150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0148
AC:
2254
AN:
152236
Hom.:
29
Cov.:
32
AF XY:
0.0140
AC XY:
1041
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.00327
AC:
136
AN:
41544
American (AMR)
AF:
0.0168
AC:
257
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.0441
AC:
153
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5184
South Asian (SAS)
AF:
0.00187
AC:
9
AN:
4822
European-Finnish (FIN)
AF:
0.0153
AC:
162
AN:
10618
Middle Eastern (MID)
AF:
0.0616
AC:
18
AN:
292
European-Non Finnish (NFE)
AF:
0.0212
AC:
1439
AN:
68000
Other (OTH)
AF:
0.0237
AC:
50
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
116
232
348
464
580
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0199
Hom.:
92
Bravo
AF:
0.0146
Asia WGS
AF:
0.00346
AC:
12
AN:
3478
EpiCase
AF:
0.0218
EpiControl
AF:
0.0232

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hereditary spherocytosis type 5 Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Nov 26, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Jan 19, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.75
CADD
Benign
8.3
DANN
Benign
0.78
PhyloP100
-0.94
PromoterAI
-0.017
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000083
dbscSNV1_RF
Benign
0.018
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs45498491; hg19: chr15-43499393; API